Sterling Capital Management
WST icon

Sterling Capital Management’s West Pharmaceutical WST Stock Holding History

Sterling Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.69M Sell
15,359
-545
-3% -$192K 0.12% 161
2026
Q2 		$5.71M Sell
15,904
-660
-4% -$202K 0.1% 186
2026
Q1 		$4.15M Sell
16,564
-1,984
-11% -$494K 0.08% 205
2025
Q4 		$5.1M Sell
18,548
-1,714
-8% -$469K 0.08% 193
2025
Q3 		$5.32M Buy
20,262
+67
+0.3% +$16.3K 0.08% 172
2025
Q2 		$4.42M Buy
20,195
+3,017
+18% +$645K 0.06% 215
2025
Q1 		$3.85M Sell
17,178
-690
-4% -$190K 0.06% 217
2024
Q4 		$5.85M Buy
17,868
+473
+3% +$149K 0.08% 178
2024
Q3 		$5.22M Buy
+17,395
New +$5.33M 0.07% 209
2019
Q3 		$27.8M Sell
196,173
-25,500
-12% -$3.51M 0.26% 111
2019
Q2 		$27.7M Hold
221,673
– – 0.27% 109
2019
Q1 		$24.4M Sell
221,673
-50,000
-18% -$5.2M 0.24% 121
2018
Q4 		$26.6M Sell
271,673
-65,232
-19% -$7.08M 0.29% 108
2018
Q3 		$41.6M Hold
336,905
– – 0.38% 94
2018
Q2 		$33.5M Hold
336,905
– – 0.31% 96
2018
Q1 		$29.7M Buy
336,905
+39,424
+13% +$3.69M 0.28% 108
2017
Q4 		$29.4M Sell
297,481
-44,979
-13% -$4.41M 0.27% 102
2017
Q3 		$33M Buy
342,460
+15,160
+5% +$1.37M 0.31% 98
2017
Q2 		$30.9M Sell
327,300
-70,000
-18% -$6.44M 0.3% 98
2017
Q1 		$32.4M Sell
397,300
-654
-0.2% -$54.7K 0.31% 98
2016
Q4 		$33.8M Sell
397,954
-37,346
-9% -$2.94M 0.3% 96
2016
Q3 		$32.4M Hold
435,300
– – 0.3% 95
2016
Q2 		$33M Sell
435,300
-117,000
-21% -$8.51M 0.3% 98
2016
Q1 		$38.3M Sell
552,300
-96,000
-15% -$5.78M 0.35% 95
2015
Q4 		$39M Hold
648,300
– – 0.35% 97
2015
Q3 		$35.1M Buy
+648,300
New +$37.8M 0.31% 104

Other funds holding WST

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Sterling Capital Management's WST Position: Q3 2026 in Review

Sterling Capital Management reduced its West Pharmaceutical (WST) stake by 3.4% in Q3 2026, selling an estimated $192K and leaving 15,359 shares worth $5.69M. The position accounts for 0.12% of the portfolio, ranked #161.

Sterling Capital Management first reported a position in WST in Q3 2015 and has held it in 26 quarters since. The position peaked at $41.6M in Q3 2018. 716 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Sterling Capital Management held 15,359 shares of West Pharmaceutical worth $5.69M as of Q3 2026.
  • Sterling Capital Management sold 545 West Pharmaceutical shares in Q3 2026, an estimated $192K.
  • West Pharmaceutical made up 0.12% of Sterling Capital Management's portfolio in Q3 2026, its #161 holding.
  • Sterling Capital Management first reported a position in West Pharmaceutical in Q3 2015 and has held it in 26 quarters since.
  • Sterling Capital Management's West Pharmaceutical position peaked at $41.6M in Q3 2018.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.